Management of adverse events from datopotamab deruxtecan in NSCLC

preview_player
Показать описание
Alexander Spira, MD, PhD, Virginia Cancer Specialist, Fairfax, VA, comments on the adverse events of datopotamab deruxtecan (Dato-DXd), an antibody-drug conjugate (ADC), in patients with non-small cell lung cancer (NSCLC). Common side effects include mucositis, which can be managed with oral rinses and good mouthcare, as well as corneal adverse events, which can be treated with eyedrops. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
  1. VJOncology
  2. Speaker: Alexander Spira
  3. Institution: Virginia Cancer Specialist
  4. Event: WCLC 2024
  5. Format: Interview
  6. Subject: Lung Cancer
Рекомендации по теме
Management of adverse 0:01:05

Management of adverse events from datopotamab deruxtecan in NSCLC

Managing Adverse Events 0:12:53

Managing Adverse Events with New Therapeutic Approaches

HCC: Management of 0:12:53

HCC: Management of Adverse Events with New Therapeutic Approaches

Managing the adverse 0:01:57

Managing the adverse events of immune checkpoint inhibitors

Management of Adverse 0:21:53

Management of Adverse Events with Newer Therapeutic Approaches

Dr. Puzanov on 0:02:12

Dr. Puzanov on Management of Adverse Events in Melanoma

Management of immunotherapy-related 0:01:09

Management of immunotherapy-related adverse events in RCC

Management of immune-related 0:08:42

Management of immune-related adverse events in ICI therapy

Diabetes BREAKTHROUGH with 0:06:44

Diabetes BREAKTHROUGH with The Poseidon Study!

Adverse Events Management 1:36:42

Adverse Events Management in Clinical Drug Trials

Improving management of 0:02:12

Improving management of adverse events in CAR-T patients

Clinical trials investigating 0:02:48

Clinical trials investigating the management of immune-related adverse events

Management strategies for 0:20:09

Management strategies for one adverse event from experienced nurse practitioners: Episode 1

PARPi: Management of 0:53:35

PARPi: Management of Adverse Events

Lithium Adverse Events 0:06:20

Lithium Adverse Events Management: Lecture Series

Management of BTKi 0:28:03

Management of BTKi Associated Adverse Events: A Nurse's Perspective

PARPi: Management of 0:53:08

PARPi: Management of Adverse Events (2024)

Management of Adverse 0:14:45

Management of Adverse Effects in R/R HER2+ mBC

UROwebinar: Adverse events 0:58:26

UROwebinar: Adverse events and toxicity management of mPCa patients from an MDT perspective

Management of BTKi 0:42:24

Management of BTKi Associated Adverse Events: A Pharmacist's Perspective

HCC Whiteboard #3: 0:03:12

HCC Whiteboard #3: The Management of Adverse Events of Tyrosine Kinase Inhibitors

Management of BTK 0:04:22

Management of BTK class driven adverse events

Managing Adverse Events 0:26:28

Managing Adverse Events with Susanna Stanford and Sarah Seddon

Managing Adverse Events 0:18:35

Managing Adverse Events of Novel Antibody-Drug Conjugates in Breast Cancer